Why Mesoblast Shares Are Trading Higher By 13%? Here Are Other Stocks Moving In Monday's Mid-Day Session

Shares of Mesoblast Limited MESO rose sharply during Monday’s session after the company announced FDA support of an accelerated approval pathway for rexlemestrocel-L in end-stage heart failure patients.

Mesoblast shares jumped 13.4% to $2.4399 on Monday.

Here are some other stocks moving in today's mid-day session.

Gainers

• Kidpik Corp. PIK gained 238% to $9.15. Kidpik recently announced a 1-for 5 reverse stock split.
• TC Biopharm (Holdings) Plc TCBP shares surged 149% to $2.6450.
• TRxADE HEALTH, Inc. MEDS gained 114.6% to $17.26. TRxADE Health recently announced a special cash dividend of $8 per share.
• Fangdd Network Group Ltd. DUO shares climbed 108% to $1.2593 after the company announced its 2024 strategic layout with plans to enter the real estate stock asset services sector.
• GDS Holdings Limited GDS shares gained 23.7% to $7.93 following a report suggesting Hillhouse and Boyu are in talks to invest in the company's Southeast Asia data center business.
• Solidion Technology Inc. STI rose 23.3% to $0.9620.
• Kingsoft Cloud Holdings Limited KC shares gained 23.1% to $3.31. Kingsoft Cloud is expected to report fourth-quarter financial results on March 20, 2024.
• EHang Holdings Limited EH gained 21.7% to $13.89. EHang Holdings is expected to release its unaudited financial results for the fourth quarter on March 15, 2024.
• Bally's Corporation BALY gained 21.5% to $12.90. Standard General delivered a non-binding letter to the board of directors of Bally's proposing a transaction under which it would acquire all of the outstanding shares of common stock for $15/share, not currently owned by the company.
• Rail Vision Ltd. RVSN climbed 21.2% to $3.43. Rail Vision received an order from a Class 1 US railroad company for its AI-based safety system.
• Marpai, Inc. MRAI gained 18.7% to $2.0899.
• bioAffinity Technologies, Inc. BIAF climbed 18.3% to $1.81.
• Lixiang Education Holding Co., Ltd. LXEH gained 15.6% to $4.8797.
• Lexicon Pharmaceuticals, Inc. LXRX jumped 13.4% to $2.4650 after the company said it is preparing to resubmit its Sotagliflozin NDA for Type 1 diabetes following FDA feedback. Additionally, the company announced a securities purchase agreement expected to result in gross proceeds of around $250 million.
• NWTN Inc. NWTN gained 13.4% to $4.8082.
• Pulse Biosciences, Inc. PLSE rose 12.7% to $10.86. Pulse Biosciences announced FDA 510(k) clearance for Cellfx NSPFA Percutaneous Electrode System.
• Bilibili Inc. BILI gained 12.7% to $12.55 after JP Morgan upgraded the stock from Underweight to Neutral and raised its price target from $10 to $11. The stock is also gaining amid overall China strength following the annual National People's Congress event.
• Graphite Bio, Inc. GRPH climbed 11.7% to $3.5080. Graphite Bio declared a special dividend in connection with proposed merger with Lenz Therapeutics.
• STAAR Surgical Company STAA jumped 10% to $39.45 after Stifel upgraded the stock from Hold to Buy and raised its price target from $30 to $50.
• VNET Group, Inc. VNET rose 9.8% to $1.68.
• Moderna, Inc. MRNA gained 9.2% to $112.51.
• Ituran Location and Control Ltd. ITRN climbed 7.8% to $28.42.
• NuScale Power CorporationSMR gained 7% to $5.87. NuScale Power is expected to release fourth quarter results on March 14, 2024.
• MicroStrategy Incorporated MSTR gained 4.7% to $1,492.07 amid continued strength in Bitcoin.

Losers

• Jeffs' Brands Ltd JFBR fell 45.2% to $0.8650.
• Eltek Ltd. ELTK shares fell 20.9% to $11.00 after the company announced downbeat quarterly earnings.
• CERo Therapeutics Holdings, Inc. CERO declined 22% to $3.0822 after jumping 28% on Friday. CERo Therapeutics recently announced the publication of preclinical research analyzing CER-1236 in targeting Acute Myelogenous Leukemia tumor cells from human patients.
• The Real Good Food Company, Inc. RGF fell 19.7% to $0.5536.
• Ventyx Biosciences, Inc. VTYX dipped 18.5% to $8.09. Ventyx Biosciences reported clinical data for its NLRP3 inhibitor portfolio and issued pipeline updates at Virtual Investor Event.
• Lytus Technologies Holdings PTV. Ltd. LYT fell 15.3% to $6.78 after declining 8% on Friday. Lytus Technologies, last week, announced the launch of Lytus Cloud.
• Next.e.GO N.V. EGOX declined 15.3% to $0.0727.
• MoneyLion Inc. ML fell 15% to $63.36.
• Semilux International Ltd. SELX fell 14.8% to $1.4403 after jumping 69% on Friday.
• Lytus Technologies Holdings PTV. Ltd. LYT fell 14.6% to $6.83.
• Barnes & Noble Education, Inc. BNED dipped 13.8% to $0.7832. Barnes & Noble Education recently rescheduled its third quarter fiscal year 2024 earnings release.
• Psyence Biomedical Ltd. PBM fell 13.4% to $1.8272 after jumping 66% on Friday. The company recently announced its subsidiary, Psyence Australia, received Human Research Ethics Committee approval to initiate its Phase IIb study.
• Immuron Limited IMRN shares tumbled 12.5% to $3.3252 after dipping 16% on Friday.
• Genie Energy Ltd. GNE fell 12% to $16.67 following fourth-quarter results.
• Nanobiotix S.A. NBTX dipped 9.8% to $6.35.
• Avenue Therapeutics, Inc. ATXI fell 8.9% to $0.1749 after surging 10% on Friday.
• Super Micro Computer, Inc. SMCI dipped 8.8% to $1,039.60.
• MannKind Corporation MNKD declined 8.7% to $4.81. MannKind announced initial meal challenge data from INHALE-3 Phase 4 U.S. trial comparing afrezza head-to-head with multiple daily injections and insulin pumps.
• Poseida Therapeutics, Inc. PSTX fell 8.1% to $3.74.

Now Read This: Wall Street's Most Accurate Analysts Say Buy These 3 Energy Stocks With Over 3% Dividend Yields